EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update

Raffaele Cordiano iD, Mario Di Gioacchino iD, Rocco Mangifesta, Claudia Panzera, Sebastiano Gangemi, Paola Lucia Minciullo

Molecules · 09.08.2023 · 28 (16) · 5979

DOI: 10.3390/molecules28165979 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 09.08.2023. Verfasst von Raffaele Cordiano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy. Hauptthemen laut MEDLINE: Hypersensitivity, Drug Hypersensitivity Syndrome, Asthma. Die Arbeit wurde bisher 442-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malondialdehyde (MDA) is a compound that is derived from the peroxidation of polyunsaturated fatty acids. It has been used as a biomarker to measure oxidative stress in various biological samples in patients who are affected by a wide range of diseases. The aim of our work is to provide an updated overview of the role of MDA as a marker of oxidative stress in allergy-related diseases. We considered studies involving both paediatric and adult patients affected by rhinitis, asthma, urticaria and atopic dermatitis. The measurement of MDA was performed on different types of samples. The reported data highlight the role of serum MDA in inflammatory airway diseases. According to the literature review, the oxidative stress status in asthmatic patients, assessed via MDA determination, appears to worsen in the presence of other allergic airway diseases and in relation to the disease severity. This suggests that MDA can be a suitable marker for monitoring the disease status. However, there are several limitations in the considered studies due to the different samples used and the lack of phenotyping and description of the clinical period of patients examined. In cutaneous allergic diseases, the role of MDA is controversial because of the smallness of the studies and the heterogeneity of the samples and patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypersensitivityDrug Hypersensitivity SyndromeAsthmaAdultHumansChildMalondialdehydeOxidative Stress

Stichwörter der Autor:innen

allergyasthmaatopic dermatitisinflammationmalondialdehydeoxidative stressrhinitisurticaria

Substanzen

Malondialdehyde

Autor:innen und Institutionen

  • Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
  • Center of Advanced Science and Technology (CAST), G. D'Annunzio University, 66100 Chieti, Italy.
  • YDA-Institute of Clinical Immunotherapy and Advanced Biological Treatments, 65121 Pescara, Italy.

ORCID-Profile: Raffaele Cordiano, Mario Di Gioacchino

Zitieren

APA

Cordiano, R., Di Gioacchino, M., Mangifesta, R., Panzera, C., Gangemi, S., & Minciullo, P. L. (2023). Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update. Molecules, 28(16), 5979. https://doi.org/10.3390/molecules28165979

Vancouver

Cordiano R, Di Gioacchino M, Mangifesta R, Panzera C, Gangemi S, Minciullo PL. Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update. Molecules. 2023;28(16):5979. doi:10.3390/molecules28165979

BibTeX
@article{Cordiano2023,
  author = {Cordiano, Raffaele and Di Gioacchino, Mario and Mangifesta, Rocco and Panzera, Claudia and Gangemi, Sebastiano and Minciullo, Paola Lucia},
  title = {Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {16},
  pages = {5979},
  doi = {10.3390/molecules28165979}
}
Kostenlos starten →